CN1244533A - Zinc scutellarin as a new medicine - Google Patents

Zinc scutellarin as a new medicine Download PDF

Info

Publication number
CN1244533A
CN1244533A CN 99114810 CN99114810A CN1244533A CN 1244533 A CN1244533 A CN 1244533A CN 99114810 CN99114810 CN 99114810 CN 99114810 A CN99114810 A CN 99114810A CN 1244533 A CN1244533 A CN 1244533A
Authority
CN
China
Prior art keywords
zinc
baicaline
new drug
medicine
scutellarin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 99114810
Other languages
Chinese (zh)
Other versions
CN1199981C (en
Inventor
蔡传英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 99114810 priority Critical patent/CN1199981C/en
Publication of CN1244533A publication Critical patent/CN1244533A/en
Application granted granted Critical
Publication of CN1199981C publication Critical patent/CN1199981C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention is a new medicine synthesized with baicalin as ligand and trace element zinc as central atom. The medicine is prepared through the reaction between zinc salt and baicalin. Compared with the traditional Chinese medicine scutellaria, the present invention has higher curative effect and biological activity, and lower toxic side effect.

Description

A kind of new drug ZnBA
The invention belongs to medicine, particularly with baicaline as part, trace element zinc is as central atom synthetic new drug.
Though the Chinese herbal treatment disease has good effect, from numerous medicines, find out and extract effective ingredient by research, therefrom filter out the compound that biological activity is strong, toxic side effect is little again, this is very difficult.Baicaline is the effective ingredient in the root of large-flowered skullcap, but it only has the effect of antisepsis and anti-inflammation, and clinical application range is narrower.
The purpose of this invention is to provide a kind of new drug that makes with the effective ingredient of herbal medicine, particularly baicaline reacts the synthetic new drug with trace element, this new drug is by changing the molecular structure of baicaline, thereby reach obvious raising curative effect, increase biological activity, reduce toxic side effect, initiative is than the better new drug of natural product.
Technical scheme of the present invention is: as part, trace element zinc generates ZnBA as central atom by zinc salt and baicaline reaction with baicaline, and its molecular structure of chemistry formula is:
Figure A9911481000031
In above-mentioned reaction, zinc salt can adopt zinc acetate, zinc chloride or zinc sulfate, and baicaline can extract from baikal skullcap root, and its purity can be more than 95%, and the pH value of baicaline lysate is between 6.5~7.0 during reaction.
Below, provide two specific embodiments that make this new drug, so that it is further described.
Embodiment 1: (Scutellaria baicalensis. S.amoena. S.likiangensis) is that raw material is made the baicaline of purity more than 95% with baikal skullcap root, the distilled water that adds 5 times of amounts makes its suspendible, heating in water bath, slowly add 1% sodium hydroxid, baicaline is all dissolved, and this moment, the pH value of solution was 6.5~7.0, dripped the saturated acetic acid zinc solution, produce a large amount of orange precipitations this moment, when adding last zinc acetate solution, do not have till the precipitation generation.Heating in water bath 20 minutes was placed 30 minutes, filters, and collecting precipitation, washing is washed till till the no zine ion, and 60 ℃ of dryings obtain ZnBA.
Embodiment 2: (Scutellaria baicalensis. S.amoena. S.likiangensis) is that raw material is made the baicaline of purity more than 95% with baikal skullcap root, get 0.45 gram and be dissolved in 50 milliliter 50% methyl alcohol, the dissolving back adds 20% sodium hydroxide accent pH value to 6.5~7.0, take by weighing 0.22 gram zinc acetate again and be dissolved in 30 milliliter 50% methyl alcohol, while stirring it is splashed in the above-mentioned baicaline solution, stirred 30 minutes, refluxed 4 hours, produce a large amount of orange precipitations.Filter, collecting precipitation, distilled water wash be not till have a zine ion, and 60 ℃ of dryings obtain ZnBA.
The check of zine ion: get a washing lotion, add one 1% K 3(Fe (CN) 6), do not generate if there is precipitation, can think and not have zine ion in the washing lotion.
Clinical application: get 4.5~5 gram Xylo-Mucines and add soaked overnight in 150 ml distilled waters, heating in water bath, add each 1 gram of glycerine and TW-80, stir, add 0.5 this new drug of gram, stir, on sheet glass, launch film forming, make per 1 square centimeter film contain 1 milligram of this medicine, 70 ℃~80 ℃ dryings obtain the medicine film.This medicine film is used for the treatment of example surplus the stomatocace 600, efficient 94%, do not find side effect; Treatment cervical erosion 22 examples, efficient 92%, do not find side effect; Hemorrhage, ulcer 30 examples of treatment nasal mucosa, curative ratio 100% is not found side effect; Example surplus treatment laryngitis, the pharyngitis 30, efficient 98%, do not find side effect.Prove that from clinical observation this efficacy of new drug is remarkable, have no side effect, have good hemostasis, pain relieving, antibiotic, repair effect such as mucosal tissue.

Claims (2)

1, a kind of new drug ZnBA is characterized in that being generated by zinc salt and baicaline reaction, and its molecular structure of chemistry formula is:
Figure A9911481000021
2, by the described new drug ZnBA of claim 1, it is characterized in that zinc salt can adopt zinc acetate, zinc chloride or zinc sulfate, baicaline can extract from baikal skullcap root, and its purity can be more than 95%, and the pH value of baicaline lysate is 6.5~7.0 during reaction.
CN 99114810 1998-04-28 1999-04-19 Zinc scutellarin as a new medicine Expired - Lifetime CN1199981C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 99114810 CN1199981C (en) 1998-04-28 1999-04-19 Zinc scutellarin as a new medicine

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN98108117.7 1998-04-28
CN98108117 1998-04-28
CN 99114810 CN1199981C (en) 1998-04-28 1999-04-19 Zinc scutellarin as a new medicine

Publications (2)

Publication Number Publication Date
CN1244533A true CN1244533A (en) 2000-02-16
CN1199981C CN1199981C (en) 2005-05-04

Family

ID=25744651

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 99114810 Expired - Lifetime CN1199981C (en) 1998-04-28 1999-04-19 Zinc scutellarin as a new medicine

Country Status (1)

Country Link
CN (1) CN1199981C (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1299693C (en) * 2005-05-20 2007-02-14 昆明医学院 Method for preparing aqueous solution of complex of baicalin zinc
CN102516341A (en) * 2011-11-16 2012-06-27 西南大学 Baicalin metal complex and preparation method and application thereof
CN104725408A (en) * 2015-04-13 2015-06-24 安徽中升药业有限公司 Monocoordinate baicalin-zinc complex and preparation method thereof
CN108659082A (en) * 2018-05-25 2018-10-16 武汉轻工大学 A kind of preparation method for treating grice diarrhoea scutelloside Zn complex
CN109970800A (en) * 2019-04-29 2019-07-05 武汉轻工大学 A kind of bismuth-scutelloside complex and its preparation method and application
US10899696B2 (en) 2015-11-13 2021-01-26 Celanese International Corporation Processes for purifying acetic acid and hydrating anhydride

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1299693C (en) * 2005-05-20 2007-02-14 昆明医学院 Method for preparing aqueous solution of complex of baicalin zinc
CN102516341A (en) * 2011-11-16 2012-06-27 西南大学 Baicalin metal complex and preparation method and application thereof
CN102516341B (en) * 2011-11-16 2014-04-09 西南大学 Baicalin metal complex and preparation method and application thereof
CN104725408A (en) * 2015-04-13 2015-06-24 安徽中升药业有限公司 Monocoordinate baicalin-zinc complex and preparation method thereof
CN104725408B (en) * 2015-04-13 2016-08-24 安徽中升药业有限公司 One coordination scutelloside Zn complex and preparation method thereof
US10899696B2 (en) 2015-11-13 2021-01-26 Celanese International Corporation Processes for purifying acetic acid and hydrating anhydride
CN108659082A (en) * 2018-05-25 2018-10-16 武汉轻工大学 A kind of preparation method for treating grice diarrhoea scutelloside Zn complex
CN108659082B (en) * 2018-05-25 2021-09-24 武汉轻工大学 Preparation method of baicalin zinc complex for treating piglet diarrhea
CN109970800A (en) * 2019-04-29 2019-07-05 武汉轻工大学 A kind of bismuth-scutelloside complex and its preparation method and application

Also Published As

Publication number Publication date
CN1199981C (en) 2005-05-04

Similar Documents

Publication Publication Date Title
CN109864930A (en) A kind of composition of plant extracts with inflammation-resisting itch-stopping and preparation method thereof, application
CN100375752C (en) Oleanolic acid and its derivative, preparation method and use
CN1199981C (en) Zinc scutellarin as a new medicine
CN1397545A (en) Process for extracting 4-hydroxy-isoleucine and by-products including feungreek gum from seed of feungreek
CN108685987A (en) A kind of Chinese medicine composition and its preparation method and application
CN107281001A (en) A kind of activity conditioning spraying containing hyaluronic acid and preparation method thereof
CN100387610C (en) Process for synthesizing lacquer leafide
CN102093323B (en) Quercetin preparation method
CN108794554A (en) The preparation method of one boar mixed feeding scutelloside manganese complex
JP2846799B2 (en) Formulations for bath salts and cosmetics
CN100343270C (en) Process for extracting anticancer product from natural plant
CN101613387A (en) The method of extracting purified puerarin by utilizing ion-exchange fiber
CN1695631A (en) Method for preparing aqueous solution of complex of baicalin zinc
CN101396455A (en) Preparation method of genipin
CN1170562C (en) Medicine for treating tinea
CN1090760A (en) A kind of production method of health care medicine Coptotermes formosanus Shtrari. dry powder
CN109692142B (en) Poria cocos facial cleanser and preparation method thereof
CN101121743B (en) Process for extracting anticancer product from natural plant
CN114794314B (en) Preparation method of selenized grease
CN1080181A (en) Skin-cleaning and sore-removing liquid
CN108677530A (en) antibacterial finishing agent and its preparation method and application
CN101376640B (en) Low irritation garlicin derivative, and synthetic method and use thereof
CN111449995B (en) Water-in-oil type whitening skin care emulsion and preparation method thereof
CN1116835C (en) Far infrared and magnetic health-care necktie
CN1160537A (en) Skin care bath lotion and its production process

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20050504